About Contact Us Careers
Sign In

Nervous System Active Pharmaceutical Ingredients Market - Top Companies and Manufacturers

  • Report ID: 4212
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Companies Dominating the Nervous System Active Pharmaceutical Ingredients Landscape

    •  Pfizer, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Boehringer Ingelheim International GmbH
    • Bristol Myers Squibb Company
    • Shenzhen Hepalink Pharmaceutical Co. Ltd.
    • GSK plc
    • F. Hoffmann-La Roche Ltd
    • Cipla Inc.
    • Eli Lilly and Company
    • Novartis AG,
    • Teva Pharmaceutical Industries Ltd.
Browse Key Market Insights with Data Illustration:

In the News

  • Boehringer Ingelheim International GmbH to partner with Carthronix, a biopharmaceutical company to develop therapies based on small molecules to cure diseases associated with elderly people. The research & development are further associated with small molecule therapeutics in canine oncology.
  • F. Hoffmann-La Roche Ltd to acquire acceptance from FDA for its Biologics License Applications. The application is associated with untreated diffuse large B-cell lymphoma.

Author Credits:  Rajrani Baghel


  • Report ID: 4212
  • Published Date: Jul 26, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of nervous system active pharmaceutical ingredients is assessed at USD 218.26 Billion.

The nervous system active pharmaceutical ingredients market size was over USD 209.4 Billion in 2023 and is expected to reach USD 380.44 Billion by the end of 2036, witnessing around 4.7% CAGR during the forecast period i.e., between 2024-2036. The growing presence of chronic diseases across the globe and the growing geriatric population are the major factors driving the growth of the market.

Asia Pacific industry is estimated to be the second largest share of 30% by 2036, led by low labor costs in the region.

Pfizer, Inc., Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Shenzhen Hepalink Pharmaceutical Co. Ltd., GSK plc, F. Hoffmann-La Roche Ltd, Cipla Inc., Eli Lilly and Company, Novartis AG, Teva Pharmaceutical Industries Ltd.
Inquiry Before Buying Request Free Sample

Copyright © 2024 Research Nester. All Rights Reserved

logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample